InsiderTrades

Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD

Accepted 2025-06-09 00:00:00 ET · period of report 2025-06-05 · accession 0000950170-25-083736 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-06-09 2025-06-06 TEVA LIEBERMAN GERALD M Dir M - OptEx — +9,632 115.7K +9% —
D 2025-06-09 2025-06-05 TEVA LIEBERMAN GERALD M Dir A - Grant $0.00 +14.5K 14.5K New $0
D 2025-06-09 2025-06-06 TEVA LIEBERMAN GERALD M Dir M - OptEx $0.00 -9,632 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2025-06-06 M A 9,632 — 115,657 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
2 Derivative Restricted Share Units 2025-06-05 A A 14,492 $0.00 14,492 D — · — to — 14,492 Ordinary Shares (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F4) Restricted share units were granted on June 5, 2025 and vest on June 5, 2026.
3 Derivative Restricted Share Units 2025-06-06 M D 9,632 $0.00 0 D — · — to — 9,632 Ordinary Shares (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F3) Restricted share units were granted on June 6, 2024 and vested on June 6, 2025.